Each year, universities generate a bounty of ideas that promise better drugs, sharper diagnostics, and smarter medical devices. Too often, however, these advances expire in what innovation-watchers call the “valley of death”: the long, underfunded stretch between a successful experiment and a product robust enough to interest investors or industry. Rutgers University has spent much of the past decade trying to build a bridge across it. Its solut…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.